Abstract FDG‐PET/CT is the current state‐of‐the‐art imaging in lymphoma and plays a
central role in treatment decisions. At diagnosis, accurate staging is crucial for appropriate …

This Review focuses on the use of 18 F-fluorodeoxyglucose (18 F-FDG) PET in the
assessment of diffuse large B-cell lymphoma, follicular lymphoma, and peripheral T-cell …

Increased tumor burden is associated with inferior outcomes in many lymphoma subtypes.
Surrogates of tumor burden that are easy to measure, such as the maximum tumor …

1Department of Haematology, Queen Elizabeth Hospital, Birmingham, 2Department of
Clinical Oncology, Christie Hospital, Manchester, 3PET Imaging Centre, King's College …

Large B-cell lymphomas (LBCLs) are a biologically heterogenous group of clinically
aggressive malignancies arising from mature B lymphocytes. Current classification systems …

Purpose Fluorine-18 fluorodeoxyglucose positron emission tomography combined with
computed tomography (FDG PET/CT) is the standard for staging aggressive non-Hodgkin …

Accurate and reproducible staging is crucial for management of malignant lymphomas.
Disease stage influences treatment decisions more significantly than any other clinical …

Since the mid-1990s, 18F-fluorodeoxglucose (FDG)-positron emission tomography (PET) in
combination with computed tomography has come to play a prominent role in the …

Bone marrow involvement in lymphoma may have prognostic and therapeutic
consequences. Bone marrow biopsy (BMB) is the established method for the evaluation of …

Background Current radiological assessments of 18fluorodeoxyglucose-positron emission
tomography (FDG-PET) imaging data in diffuse large B-cell lymphoma (DLBCL) can be time …